[ummonk]

He identified the microfluidic liquid nanoparticle assembly machines as the bottleneck but didn't specify why their manufacture can't be spread up. We should be purchasing the IP for hundreds of billions of dollars and open sourcing the technology, not leaving it up to the companies to slowly set up their facilities and build manufacturing partnerships.

[_ph_]

It wouldn't even required to purchase or transfer the IP at all, the governments should just fund the setup of the necessary production capabilities and lease them to BioNTech/Pfizer and Moderna at basically zero costs.

Vaccine production is still far to low to vaccinated the whole world population any time soon and only then we can prevent the creation of new mutant strains.